Jennifer Carter

Dr. Jennifer L.
Carter is a Chief Executive Officer at Medzown, Inc., a Managing Director at 213 Management LLC, a Managing Director at The Blue Venture Fund, a Senior Strategic Advisor at Drumroll Health, Inc., a Member-Founding Strategic Board at Xsphera Biosciences, Inc., a Member-Directors Advisory Board at Yale-New Haven Hospital, Inc., a Member at Women Business Leaders of the US Health Care Industry Fnd and a Member at Women in Bio, Inc. She is on the Board of Directors at eCaring, Inc., HouseWorks LLC and Target Cancer Foundation.
Dr. Carter was previously employed as an Independent Director by CareMax, Inc., an Independent Director by OncoCyte Corp., a Strategic Advisor by Javelin Oncology, Inc., a Managing Director by Jlc Precision Health Strategies, LLC, an Independent Director by DFP Healthcare Acquisitions Corp., a Vice President, Head-Precision Health by Valo Health, Inc., a Strategic Advisor by Q-State Biosciences, Inc., a Chief Executive Officer by Trialzown, Inc., a Founder, President & Chief Medical Officer by N-of-One, Inc., an Investment Consultant by Levin Capital Strategies LP, and a Consultant by JLC Enterprises, Inc. She received her undergraduate degree from Yale University, a graduate degree from Harvard T.H.
Chan School of Public Health, an MBA from MIT Sloan School of Management and a doctorate degree from Harvard Medical School.